EXPLAINED: Als association - The Real Truth

Why Pasithea Therapeutics (KTTA) Stock Is Suddenly On Fire Today

Pasithea Therapeutics Corp (NASDAQ:KTTA) shares are trading sharply higher Wednesday morning after a string of upbeat updates on its lead drug candidate, PAS-004, capped by a new $1 million grant from the ALS Association. Here’s what investors need to know.

Benzinga · Nov 26, 2025

What is ALS and what are the causes?

Progressive neurodegenerative disease suffered by legendary singer Roberta Flack affects nerve cells in the brain and spinal cord

The Independent UK · Nov 15, 2022

Ice bucket challenge helps to fund FDA-approved motor neurone medication

Millions of dollars raised during the ice bucket challenge craze of 2014 have been used in the development of a new FDA-approved treatment.

The New Daily · Oct 4, 2022